Colgate-Palmolive India Reports Q3FY26 Results with 1.4% Revenue Growth

2 min read     Updated on 29 Jan 2026, 07:43 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Colgate-Palmolive (India) Limited reported Q3FY26 results with net sales of Rs. 1,473 crore, up 1.4% YoY. Net profit stood at Rs. 324 crore, growing 2.3% excluding exceptional items from new labour code implementation. The company maintained robust gross margins at 69.7%, improving 50 bps quarter-on-quarter, while accelerating premium segment investments and launching innovative products like Colgate Visible White Purple Serum.

31241604

*this image is generated using AI for illustrative purposes only.

Colgate-Palmolive (India) Limited announced its unaudited financial results for the third quarter ended December 31, 2025, showing a return to growth momentum driven by improved performance across urban and rural channels. The company reported steady revenue growth while maintaining robust profitability despite regulatory headwinds.

Financial Performance Overview

The company delivered solid financial performance for the third quarter of FY26, with revenue growth supported by recovery in core portfolio and sustained premium segment performance.

Metric Q3 FY26 Q3 FY25 Growth (%)
Net Sales Rs. 1,473 crore Rs. 1,452 crore +1.4%
Net Profit (reported) Rs. 324 crore Rs. 323 crore +0.3%
Net Profit (excluding exceptional items) Rs. 332 crore Rs. 323 crore +2.3%
Gross Margin 69.7% - +50 bps QoQ
Earnings Per Share Rs. 11.91 Rs. 11.87 +0.3%

Operational Highlights

The quarter witnessed improved momentum across both urban and rural trade channels, indicating recovery following disruption from revised GST rate implementation. Domestic net sales grew by 2.2% year-on-year, while the premium segment continued to deliver strong double-digit growth.

Managing Director & CEO Prabha Narasimhan commented on the performance: "In the third quarter, our business saw a return to growth, driven by early positive signs in our core portfolio and sustained strong performance in the premium segment. Both urban and rural trade channels experienced improved momentum throughout the quarter."

Margin Performance and Cost Management

The company maintained robust gross margin profile through strict financial discipline via its funding the growth program. Q3 FY26 margin reached 69.7%, improving by 50 basis points compared to the trailing quarter. However, net profit growth was impacted by regulatory changes, including the new labour code implementation and inverted duty structure charges due to GST changes.

Product Innovation and Market Strategy

During the quarter, Colgate accelerated brand investments in the premium segment as part of its premiumisation strategy within the oral care category. The company successfully launched Colgate Visible White Purple Serum in Q3, marking a significant milestone in its "Oral Beauty" journey.

Innovation Highlights Details
New Product Launch Colgate Visible White Purple Serum
Technology Advanced color-correction technology
Market Access 60g access pack of Visible White Purple toothpaste
Category Focus Premium oral care segment

The innovative whitening booster leverages advanced color-correction technology to neutralize yellow tones, providing consumers with instant, on-demand brightening effects. Additionally, the company introduced a 60g access pack of Visible White Purple toothpaste to make premium products more accessible.

Exceptional Items and Regulatory Impact

The company recorded exceptional expenses of Rs. 839 lakhs during the quarter due to the implementation of new labour codes notified by the Government of India on November 21, 2025. These codes consolidate existing labour laws, resulting in a one-time increase in employee benefit expenses recognized under exceptional items.

Nine-Month Performance

For the nine months ended December 31, 2025, total income stood at Rs. 4,512 crore compared to Rs. 4,697 crore in the corresponding period of the previous year. Net profit for the nine-month period was Rs. 972 crore compared to Rs. 1,082 crore in the previous year.

Outlook and Strategy

The company expects growth momentum to accelerate going forward, driven by an improving demand environment and intense focus on superior execution. The management remains committed to advancing premiumisation strategy while maintaining financial discipline through funding the growth initiatives.

Historical Stock Returns for Colgate Palmolive

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-0.49%+1.21%-4.22%-21.15%+35.07%

Colgate-Palmolive India Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results

1 min read     Updated on 20 Jan 2026, 05:13 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Colgate-Palmolive (India) Limited has scheduled a board meeting for January 29, 2026, to approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting complies with SEBI Regulation 29 requirements. The company's trading window, closed since December 29, 2025, will reopen 48 hours after results publication.

30455038

*this image is generated using AI for illustrative purposes only.

Colgate Palmolive (India) Limited has announced that its Board of Directors will convene on January 29, 2026, to approve the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. The announcement was communicated to both BSE Limited and National Stock Exchange of India Limited on January 20, 2026.

Board Meeting Details

The meeting has been scheduled in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review and approve the unaudited financial results for Q3FY26, covering the performance for the quarter and nine-month period ending December 31, 2025.

Meeting Details: Information
Date: January 29, 2026
Purpose: Approve Q3FY26 unaudited financial results
Period Covered: Quarter and nine months ended December 31, 2025
Regulatory Compliance: SEBI Regulation 29

Trading Window Status

The company has reiterated that the trading window remains closed from December 29, 2025, as previously communicated in their letter dated December 27, 2025. The trading window will reopen 48 hours after the financial results are made public, ensuring compliance with insider trading regulations.

Company Information

Colgate-Palmolive (India) Limited is registered with CIN L24200MH1937PLC002700 and has its registered office at Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai - 400076. The company is listed on both major Indian stock exchanges with scrip code 500830 on BSE and symbol COLPAL in the EQ series on NSE.

The announcement was signed by Jaikishan Shah, Company Secretary and Compliance Officer (Membership No: A34948), who digitally signed the communication on January 20, 2026, at 16:26:40 +05'30'.

Historical Stock Returns for Colgate Palmolive

1 Day5 Days1 Month6 Months1 Year5 Years
-1.94%-0.49%+1.21%-4.22%-21.15%+35.07%

More News on Colgate Palmolive

1 Year Returns:-21.15%